Diazoxide Choline Patent Expiration
Diazoxide Choline was first introduced by Soleno Therapeutics Inc
Diazoxide Choline Patents
Given below is the list of patents protecting Diazoxide Choline, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Vykat Xr | US12178823 | Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome | Nov 12, 2035 | Soleno Therap |
| Vykat Xr | US9757384 | Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome | Nov 12, 2035 | Soleno Therap |
| Vykat Xr | US7799777 | Salts of potassium ATP channel openers and uses thereof | Mar 05, 2029 | Soleno Therap |
| Vykat Xr | US7572789 | Salts of potassium ATP channel openers and uses thereof | Dec 20, 2026 | Soleno Therap |
Diazoxide Choline's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List